Skip Navigation

Display Mode:

  • Choose Default Style
  • Choose High Contrast
PAMF California Prostate Cancer Care
  • Prostate Home
  • Contact Us
  • PAMF Home
  • About Prostate Cancer
  • Integrated Medical Team
  • Treatment Options
  • Resources
  • Location & Directions
Section TitleAbout Prostate Cancer
  • Risk Factors
  • Prevention
  • Symptoms
  • Screening & Diagnosis
  • Biopsy
  • Stages of Prostate Cancer
    Main content

    Stages of Prostate Cancer

    If cancer is found in the prostate, your doctor needs to know the stage, or extent, of the disease. Staging is an attempt to determine whether the cancer has spread and, if so, what areas of the body are affected. Various blood and imaging tests are used to learn the stage of the disease. Treatment decisions depend on these findings.

    In general, the different systems attempt to classify stage of the cancer by evaluating the following:

    • The size and location of the primary prostate tumor
    • Whether the cells have spread beyond the prostate gland and to other organs or areas
    • Whether the cells have spread to lymph nodes
    • Whether the cancer cells have metastasized into another part of the body
    The stages below represent the common staging system in the United States used for prostate cancer. The system, called TNM, describes the extent of the primary tumor (T), if the cancer has metastasized to lymph nodes (N) and if the cancer has metastasized elsewhere (M). There are two types of stages: the clinical stage (based on the digital rectal exam, needle biopsy or transrectal ultrasound results) and the pathological stage (based on surgical removal of the entire prostate gland, the seminal vesicles and possibly lymph nodes.

    • T Stages (Primary Tumor)
    • N Stages (Regional Lymph Nodes)
    • M Stages (Distant Metastasis)

    T Stages (Primary Tumor)

    In the T stages, the cancer is localized in the prostate gland and surrounding areas.

    Clinical
    TX -- Primary tumor cannot be assessed
    T0 -- No evidence of primary tumor
    T1 -- Cannot detect tumor with imaging tests
    T1a -- Less than 5 percent of the prostate is affected by the tumor
    T1b -- More than 5 percent of the prostate is affected by the tumor
    T1c -- Tumor identified by needle biopsy, PSA elevated
    T2 -- Tumor confined within prostate
    T2a -- Tumor affects one-half of one lobe or less
    T2b -- Tumor affects more than one-half of one lobe but not both lobes
    T2c -- Tumor affects both lobes
    T3 -- Tumor extends through the prostate capsule
    T3a -- Tumor extends beyond the prostate capsule
    T3b -- Tumor invades seminal vesicle(s)
    T4 -- Tumor is fixed or invades surrounding areas, such as the bladder neck, external sphincter, rectum, levator muscles, and/or pelvic wall

    Pathologic
    pT2 -- Tumor confined to the prostate
    pT2a -- Tumor affects one-half of one lobe or less
    pT2b -- Tumor affects more than one-half of one lobe but not both lobes
    pT2c -- Tumor affects both lobes
    pT3 -- Tumor extends beyond the prostate
    pT3a -- Tumor extends beyond the prostate
    pT3b -- Tumor invades seminal vesicle(s)
    pT4 -- Tumor invades the bladder, rectum


    Back to top

    N Stages (Regional Lymph Nodes)

    A N0 stage indicates the cancer has not spread to the lymph nodes. N1 indicates the cancer has spread to one or more pelvic lymph nodes.

    Clinical
    NX -- Regional lymph nodes were not assessed
    N0 -- Tumor has not spread to regional lymph nodes
    N1 -- Tumor has spread to regional lymph nodes

    Pathologic
    pNX -- Regional lymph nodes were not assessed
    pN0 -- Regional lymph nodes not affected by tumor
    pN1 -- Regional lymph nodes affected by tumor


    Back to top

    M Stages (Distant Metastasis)

    A M0 stage indicates the cancer has not metastasized beyond the local lymph nodes, while M1 indicates the cancer has metastasized to distant lymph nodes and/or to other organs.

    MX -- Distant metastasis cannot be assessed
    M0 -- No distant metastasis
    M1 -- Distant metastasis
    M1a -- Non-regional lymph nodes affected by tumor
    M1b -- Bones affected by tumor
    M1c -- Other sites affected by tumor with or without bone disease
    Back to top

    • Privacy Policy
    • Site Map
    • Website Feedback

    © 2013 Palo Alto Medical Foundation. All rights reserved. Sutter Health is a registered trademark of Sutter Health®, Reg. U.S. Patent. & Trademark office.
    Serving communities around Palo Alto, Mountain View, Fremont, San Jose, San Francisco, Oakland, Dublin, San Mateo & Santa Cruz.